Lightox

Website

Advertisement

65 Westgate Road
Newcastle upon Tyne, England NE1 1SG

LightOx, headquartered in Newcastle upon Tyne, UK, is at the forefront of developing innovative light-activated drug compounds aimed at treating early-stage mouth cancers and precancerous lesions. Their lead candidate is anticipated to enter Phase III clinical trials in 2025, with a focus on improving patient outcomes through novel therapeutic solutions.

The company is pioneering a new class of light-activated chemotherapy that could be administered in a dentist's chair, utilising a gel applied to affected areas, which is activated by light. This method promises to offer a swift and simple alternative to traditional surgery, with fewer side effects.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Advertisement